Literature DB >> 20397777

A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients.

Ulf Isacsson1, Kristina Nilsson, Stefan Asplund, Elizabeth Morhed, Anders Montelius, Ingela Turesson.   

Abstract

UNLABELLED: The use of protons for curative treatment of prostate cancer is increasing, either as a single treatment modality or in combination with conventional radiotherapy. The proximity between prostate (target) and rectum (organ at risk) often leads to a compromise between dose to target and organ at risk.
MATERIAL AND METHODS: The present study describes a method where the distance between prostate and rectum is increased by retraction of the rectum in dorsal direction. Comparative treatment plans with and without retraction of the rectum in the same patients have been studied. Nine patients with biopsy proven, localised adenocarcinoma of the prostate were studied. A cylindrical rod of Perspex was inserted into the rectum. This device allows the rectum to be retracted posteriorly. The patients were given a proton boost of 20 Gy in four fractions of 5 Gy in addition to a conventional photon beam treatment to a dose of 50 Gy in 25 fractions of 2 Gy.
RESULTS: Comparative treatment planning shows that the treatment plan with rectal retraction significantly reduces (p<0.01) the volume of the rectal wall receiving high doses (equal to 70 Gy in 2 Gy fractions) in all patients.
CONCLUSIONS: The proton boost treatment with retraction of rectum during treatment decreases the rectal dose substantially. This is expected to reduce rectal side effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20397777     DOI: 10.3109/02841861003745535

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  13 in total

Review 1.  The contribution of women to radiobiology: Marie Curie and beyond.

Authors:  Anna Gasinska
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

Review 2.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

3.  PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.

Authors:  Simone Däpp; Cristina Müller; Elisa García Garayoa; Peter Bläuenstein; Veronique Maes; Luc Brans; Dirk A Tourwé; Roger Schibli
Journal:  EJNMMI Res       Date:  2012-06-09       Impact factor: 3.138

4.  Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR).

Authors:  Alexandru Nicolae; Melanie Davidson; Harry Easton; Joelle Helou; Hima Musunuru; Andrew Loblaw; Ananth Ravi
Journal:  Radiat Oncol       Date:  2015-05-30       Impact factor: 3.481

5.  Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.

Authors:  Kimberley Legge; Peter B Greer; Daryl J O'Connor; Lee Wilton; Matthew Richardson; Perry Hunter; Alex Wilfert; Jarad Martin; Anatoly Rosenfeld; Dean Cutajar
Journal:  Radiat Oncol       Date:  2017-02-27       Impact factor: 3.481

6.  PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.

Authors:  Matthew Richardson; Mark Sidhom; Sarah Gallagher; Mel Grand; David Pryor; Joseph Bucci; Lee Wilton; Sankar Arumugam; Sarah Keats; Jarad M Martin
Journal:  BMC Cancer       Date:  2018-05-24       Impact factor: 4.430

7.  Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?

Authors:  Angèle Dubouloz; Michel Rouzaud; Lev Tsvang; Wilko Verbakel; Mikko Björkqvist; Nadine Linthout; Joana Lencart; Juan María Pérez-Moreno; Zeynep Ozen; Lluís Escude; Thomas Zilli; Raymond Miralbell
Journal:  Radiat Oncol       Date:  2018-06-19       Impact factor: 3.481

8.  Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.

Authors:  Silvia Johansson; Lennart Aström; Fredrik Sandin; Ulf Isacsson; Anders Montelius; Ingela Turesson
Journal:  Prostate Cancer       Date:  2012-07-08

9.  Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy - applied to prostate proton treatments.

Authors:  David Tilly; Nina Tilly; Anders Ahnesjö
Journal:  BMC Med Phys       Date:  2013-06-14

10.  Real-time intrafraction prostate motion during linac based stereotactic radiotherapy with rectal displacement.

Authors:  Kimberley Legge; Doan Nguyen; Jin Aun Ng; Lee Wilton; Matthew Richardson; Jeremy Booth; Paul Keall; Darryl J O'Connor; Peter Greer; Jarad Martin
Journal:  J Appl Clin Med Phys       Date:  2017-09-27       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.